There is a new study beginning the spring/summer of 2007 in Warrenton, VA to address the excessive dry mouth patients experience after undergoing radiation treatment for head & neck cancer. The primary objective is to assess the impact of the drug Evoxac (cevimeline) on salivary flow at a dose of 30mg three times daily. Of note, this drug and dosage has already been approved by the FDA for treatment of dry mouth in patients with Sjogren's syndrome, an autoimmune disease that causes dry mouth.
Fauquier ENT is one of only 13 sites nationally participating in this study which is coordinated by the Duke Clinical Research Institute and the American Academy of Otolaryngology-Head & Neck Surgery.
Contact our office if you would like to participate in this study. This study is anticipated to be completed end of 2008.
A recently published article suggested that tonsillectomy was associated with a decrease in the incidence and frequency and an increase in the time to the next infection in children with recurrent strep throat.
This finding is something many ENTs have suspected, but now there is evidence to support.
Reference: Efficacy of Tonsillectomy in Treatment of Recurrent Group A B-Hemolytic Streptococcal Pharyngitis. Laryngoscope. 116:1946-1950. 2006. Link